Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Results published in The Lancet showed significant improvements in both weight and glycemic control (Rosenstock et al., 2023): Participants lost up to 16.9% of body weight (lower than the non-diabetic cohort, consistent with other medication studies) HbA1c reductions of up to 2.02 percentage points , bringing many participants into the normal range Significant improvements in fasting glucose and insulin sensitivity Phase 3 Trials Eli Lilly initiated Phase 3 clinical trials for retatrutide in late 2023
Pharmacol Ther 2014;141:1509
Amalgam tattoo
Information for prescribers Cautions/contraindications Hypersensitivity to the active substance or to any of the excipients (sodium phosphate dibasic heptahydrate, sodium chloride, concentrated hydrochloric acid and sodium hydroxide, glycerol, phenol, benzyl alcohol, water)
Glycine is an amino acid with multiple potential benefits during weight loss protocols including improved sleep quality, anti-inflammatory effects, and support for collagen synthesis during rapid body composition changes
